Introduction
The aryl hydrocarbon receptor (AHR), a member of the Per-ARNT-Sim (HLH-PAS) family, is known to be a ligand-activated transcription factor [1] . In the absence of ligand, the AHR resides in the cytoplasm where it is associated with heat-shock protein 90 [2] , the cochaperone protein p23 [3] , and hepatitis B virus X-associated protein 2 [4] [5] [6] . After binding of ligand, the AHR translocates to the nucleus where it dimerizes with a protein known as AHR translocator (ARNT) [7, 8] . The dimer then recognizes its cognate DNA sequence, termed xenobiotic responsive element (XRE), and modulates expression of a battery of genes [1] .
Most of our knowledge of AHR/ARNT-regulated transcription comes from studies of the induction of the cytochrome P4501A1 (CYP1A1) gene by a wide spectrum of xenobiotic chemicals including polycyclic and halogenated aromatic hydrocarbons and aromatic amines, e.g. dioxins, 3-methylcolanthrene, and beta-naphthoflavone. AHR ligands have certain common characteristics with respect to their chemical structure; they are hydrophobic, planar, or coplanar molecules of polycyclic structure [9] .
For a long time, researchers have made extensive efforts to identify an endogenous ligand of the AHR. Previous reports have proposed reliable evidence that tryptophan and its metabolites could act as endogenous agonists at the AHR and induce AHR-regulated gene transcription both in vivo and in cultured cells [10, 11] . In addition, there is evidence of a ligand-independent pathway that a variety of agents can transcriptionally activate CYP1A1, as measured by the AHR response, including hormones, omeprazole, and notably carotenoids, even though they lack the chemical characteristics typically associated with high AHR affinity [12] [13] [14] [15] [16] [17] [18] . However, there is no definitive explanation for the physiological function of AHR in the various tissues in which it is expressed, particularly when addressing the question of which endogenous compounds regulate AHR at physiological concentrations, the exception being tryptophan.
Our previous studies have reported that the AHR can be activated by carotenoids which are dietary constituents [17, 18] . Retinoids, the most abundant end products of carotenoids, are well known endogenous compounds which can exert various bioactivities via the retinoic acid receptor (RAR). However, there is little information on the effect of retinoic acid on AHR-mediated gene regulation. Therefore, we investigated the effects of all-trans retinoic acid (atRA) on gene regulation by the AHR. The physiological concentration of total retinoic acid (RA) is reported to be 30-100 pmol/g in rat and mouse liver [19, 20] , and that of atRA is concentration and quality were checked by using a Nanodrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Waltham, Massachusetts, USA). The RNA quality was estimated from the 260/280 and 260/230 nm absorbance ratios and confirmed by denaturing agarose gel electrophoresis. We synthesized cDNA from 500 ng of total RNA using a Takara Revetra kit (Takara, Ohtsu, Japan). The levels of CYP1A1 mRNA were measured using an Applied Biosystems StepOne™ Real-Time PCR System (Foster, CA, USA), as described below. We employed the comparative CT quantification (ΔΔCt) qrtPCR method to compare changes in CYP1A1 gene expression. Relative quantification was performed using Glucuronidase beta (GUSB) as an endogenous control gene. The gene bank accession numbers, and Applied Biosystems assay IDs were, respectively: NM_000499.3 and Hs00153120_m1 (CYP1A1), and NM_000181.3 and Hs00939627_m1 (GUSB). An identical set of PCR cycle parameters was used for all genes: 95°C for 10 min, and 40 cycles at 95°C for 15 sec and 60°C for 30 sec, which was validated by Applied Biosystems.
Gene silencing with siRNA
Double-stranded siRNAs targeting human RARα (GeneBank accession no. NM_000964) were purchased from Sigma Genosys. Negative control siRNA from Ambion (Austin, TX, USA) was used in control experiments. HepG2 cells were transfected with siRNAs at 50 nM using siPORT Neo FX Transfection Agent (Ambion), according to the supplier's protocol.
Thirty-six hours after transfection, the media were replaced with fresh medium containing 0.1% DMSO or 100 nM atRA. After incubation at 37°C for 20 h, the expression levels of CYP1A1 and RARα were measured by real time PCR as previously described.
Reporter plasmid construction
The pGL3-XRE promoter vector, a kind gift from Dr. were subjected to luciferase assays using the Dual-Glo Luciferase Assay System (Promega).
ChIP assay
HepG2 cells cultured in 100 mm diameter dishes were treated with 0.1% DMSO, 1 nM, or 100 nM atRA for 20 h. After incubation, formaldehyde (1% final concentration) was added to the media for 10 min to cross-link proteins with DNA. Cells were rinsed twice with ice-cold PBS, scraped into 1 ml ice-cold PBS containing a protease inhibitor cocktail, placed into tubes each containing 2×10 6 cells, and centrifuged at 3000 g for 5 min at 4°C. After removing the supernatants, cells were lysed with 300 µl of lysis buffer (1% SDS, 5mM EDTA, 50mM
Tris, pH 8.1, and protease inhibitor cocktail) on ice for 15 min. The solutions were then 
Statistical analysis
The mRNA expression results and relative transactivation abilities are expressed as the mean ± SD. Statistical significance was assessed using a Student's t-test; differences between observations at the p<0.05 level were considered statistically significant.
Results
Transactivation and CYP1A1 mRNA expression were inhibited by atRA.
As shown in Figure 1 RARα was required for the inhibition of CYP1A1 transactivation by atRA.
As shown in Figure 2 -A, the reduction of CYP1A1 transcription by atRA was attenuated by AGN193109, a pan-antagonist at RARs. To confirm whether the inhibitory effect of atRA on The recruitment of ARNT to DNA was inhibited by atRA.
To confirm the effects of atRA on the recruitment of transcription factors to the CYP1A1 promoter region, we employed chromatin immunoprecipitation (ChIP) assay. HepG2 cells were treated with 0-100 nM atRA for 20 h and subjected to ChIP assay with antibodies 15 against AHR and ARNT. DNAs from immunoprecipitates were amplified by PCR using a primer set which recognized the -988 to -754 bp sequences from the human CYP1A1 transcription start site, which contains two XREs. We found that AHR and ARNT were recruited to the region in the absence of AHR ligand (Figure 4 ). Treatment with atRA had no effect on the recruitment of AHR to the region. However, the recruitment of ARNT was not detected in cells treated with 1 nM or 100 nM atRA for 20 h (Figure 4 ).
Discussion
The function of AHR in ligand-free states and the constitutive regulation of CYP1A1 mRNA expression are poorly understood, whereas CYP1A1 transactivation by ligand-bound AHR has been well investigated using typical AHR ligands, including dioxins and On the other hand, Ross-Innes and colleagues have reported that RARα is an essential component for maintaining of estrogen receptor-cofactors interaction [32] . In addition, it has been reported that RARα and retinoid X receptor α can directly interact with MOP4 and CLOCK, which are classified to PAS proteins as well as AHR and ARNT, and can negatively regulate MOP4 and CLOCK-mediated transcriptional activation by RA in a concentration dependent manner [33] . These previous reports lead us to consider the possibility that ARNT, estrogen receptor, and RAR are co-localized in the nucleus, and that gene transcription mediated by any one of these factors may be modified by the others.
In summary, our current findings have indicated that atRA at physiological concentrations decreases the transactivation of CYP1A1 not through an inhibition of the recruitment of AHR, but by an inhibition of recruitment of ARNT to XRE-containing regions. We now intend to undertake a detailed study of the mechanisms of RAR interactions with AHR and ARNT. 
